Form Biovs
Benchling


Benchling: If you need general molecular biology design and registry tooling rather than AAV manufacturability prediction

Computational platform for cell and gene therapy design and manufacturability
As of 31 August 2026, Form Bio's pricing is not published; the vendor quotes on request. A cell and gene therapy computational platform that has narrowed sharply from general life sciences data tooling to AAV construct design and manufacturability prediction. Softwr lists it under Research. Form Bio is available on Web, Cloud.
Overview
Form Bio builds computational software for genetic medicine development, focused on cell and gene therapy. Its current offering, FormManufacturing, launched in 2026 as an AAV-focused platform that predicts, optimises and monitors manufacturability from construct design through to commercial scale-up, combining AI-driven payload design optimisation with deep genomic characterisation of what actually gets produced. The problem it addresses is a real one in the field: the therapy that is designed and the therapy that is manufactured consistently are frequently not the same thing, and that gap is discovered expensively and late. The history is what a buyer needs. Form Bio spun out of Colossal Biosciences in 2022 as a broader computational life sciences platform with general bioinformatics and data collaboration tooling, and has since narrowed to cell and gene therapy, and within that to AAV. That is a rational focus for a company chasing a defensible market, but it means older product descriptions, comparison articles and reference customers may describe capabilities that are no longer the commercial priority. Anything you assume from a 2023 evaluation should be re-checked. Buyers are gene therapy developers, primarily biotechs with AAV programmes, and their CDMO partners. Pricing is not published and arrives through a sales process, which for a platform of this kind normally means an annual subscription plus programme-scoped analysis work. The trade-off is concentration risk on both sides: a narrow product from a young company, applied to a programme where the analysis results shape regulatory-facing decisions.
The honest half
Concrete and checkable, so you can decide whether any of them matter to you. This is the half of a review a vendor will not write about Form Bio.
Cross-shopped
Each pairing was judged by two reviewers asking whether a buyer would genuinely weigh the two against each other. The ones that failed were deleted rather than published.


Benchling: If you need general molecular biology design and registry tooling rather than AAV manufacturability prediction
Pricing
Taken from the vendor's own pricing page. Prices move, so check before you buy.
FormManufacturing
On request
Capabilities
FormManufacturing
AAV-focused platform predicting and monitoring manufacturability from design to scale-up
Payload design optimisation
AI-driven construct and payload optimisation ahead of production
Genome integrity analysis
Deep genomic characterisation of what is actually produced versus what was designed
Manufacturability prediction
Forecasting of production risks before committing to a manufacturing run
In silico workflows
Computational analysis replacing some wet-lab iteration cycles
Scale-up monitoring
Tracking of construct behaviour through to commercial scale production
Cell and gene therapy focus
Tooling built for CGT rather than adapted from general bioinformatics
Collaboration
Shared analysis between developer and manufacturing partner
Answered, with sources
Each answer names the page it came from, so you can check it rather than take our word for it.
FormManufacturing, launched in 2026, an AAV-focused platform for predicting, optimising and monitoring manufacturability of genetic medicines from construct design through scale-up.
No. It has narrowed from broad computational life sciences tooling to cell and gene therapy, and within that to AAV.
It spun out of Colossal Biosciences in 2022.
No. Engagements are scoped per programme through a sales process.
Keep looking
Regulated cloud platform for genomic and multiomic data, with GxP and FedRAMP coverage
Research informatics group behind GraphPad Prism, SnapGene, Geneious and LabArchives, now owned by Siemens
Cloud bioinformatics platform and trusted research environment, sold by Velsera
Open biomedical research platform for genomic analysis, priced only by the cloud you consume
Computational chemistry toolkits and the Orion cloud platform, now inside Cadence
Physics based molecular modelling and drug discovery software, licensed by token pool
Science-aware laboratory platform combining LIMS, ELN and scientific data management
Cheminformatics toolkits and structure handling, now a Certara subsidiary
Electronic lab notebook, LIMS and inventory in one system, now sold under the Cenevo group
A powerful knowledge base on top of a local folder of plain text Markdown files
Edit video by editing its transcript, built for researchers rather than video editors
Live AI-moderated conversations with hundreds of participants at once, analysed in real time
No-code lab operating system combining LIMS, ELN and inventory for biotech teams
Cloud bioinformatics platform and trusted research environment, sold by Velsera
Physics based molecular modelling and drug discovery software, licensed by token pool
Softwr does not host reviews and shows no star rating for Form Bio, because a rating we did not collect is not ours to publish. What is here is the pricing and platform detail from the vendor’s own pages, limitations we could state concretely, and alternatives a reviewer confirmed people weigh against it. Tell us if any of it is wrong.
What people switch to, and what they give up
Every tier, and where the cost actually lands
Put it head to head with anything we hold
Its rating, and an embed for your own site
Science-aware laboratory platform combining LIMS, ELN and scientific data management
quoteR&D cloud for biotechnology research and molecular biology
Free for academics, quoted for organisationsUX research repository for tagging notes, building insights and finding them again years later
Flat monthly fee, unlimited usersElectronic data capture and eConsent for clinical trials, built for investigator-initiated studies as well as sponsors
quote